Found: 36
Select item for more details and to access through your institution.
Initial results with [<sup>18</sup>F]FAPI-74 PET/CT in idiopathic pulmonary fibrosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 6, p. 1605, doi. 10.1007/s00259-023-06564-y
- By:
- Publication type:
- Article
A protocol for controlled reactivity shift in the 2,2-difluorovinyl motif used for selective S–<sup>18</sup>F and C–<sup>18</sup>F bond formation.
- Published in:
- Communications Chemistry, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42004-024-01132-3
- By:
- Publication type:
- Article
Imaging GRPr Expression in Metastatic Castration-Resistant Prostate Cancer with [ 68 Ga]Ga-RM2—A Head-to-Head Pilot Comparison with [ 68 Ga]Ga-PSMA-11.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 173, doi. 10.3390/cancers16010173
- By:
- Publication type:
- Article
Tau‐PET imaging with <sup>18</sup>F‐PI‐2620 reveals lateralized distribution of tau pathology in critical language regions in patients with early onset of Alzheimer's Disease and patients with primary progressive aphasia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.067702
- By:
- Publication type:
- Article
Head-to-Head Intra-Individual Comparison of Biodistribution and Tumor Uptake of [ 18 F]FAPI-74 with [ 18 F]FDG in Patients with PDAC: A Prospective Exploratory Study.
- Published in:
- Cancers, 2023, v. 15, n. 10, p. 2798, doi. 10.3390/cancers15102798
- By:
- Publication type:
- Article
Al[ 18 F]F-NOTA-Octreotide Is Comparable to [ 68 Ga]Ga-DOTA-TATE for PET/CT Imaging of Neuroendocrine Tumours in the Latin-American Population.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 439, doi. 10.3390/cancers15020439
- By:
- Publication type:
- Article
Tau PET imaging with <sup>18</sup>F‐PI‐2620 in patients with corticobasal syndrome: a case series.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.067105
- By:
- Publication type:
- Article
Tau and amyloid PET imaging with <sup>18</sup>F‐PI‐2620 and <sup>18</sup>F‐Florbetaben in patients with early‐onset dementia and healthy controls.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.068016
- By:
- Publication type:
- Article
Whole-body biodistribution and radiation dosimetry of [<sup>18</sup>F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-021-00873-9
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of 177Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
First-In-Human Results on the Biodistribution, Pharmacokinetics, and Dosimetry of [ 177 Lu]Lu-DOTA.SA.FAPi and [ 177 Lu]Lu-DOTAGA.(SA.FAPi) 2.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1212, doi. 10.3390/ph14121212
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4946, doi. 10.3390/cancers13194946
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 1915, doi. 10.1007/s00259-020-05132-y
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 893, doi. 10.1007/s00259-020-05022-3
- By:
- Publication type:
- Article
A theranostic approach of [68Ga]Ga-DOTA.SA.FAPi PET/CT-guided [177Lu]Lu-DOTA.SA.FAPi radionuclide therapy in an end-stage breast cancer patient: new frontier in targeted radionuclide therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 942, doi. 10.1007/s00259-020-04990-w
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Evaluation of safety and dosimetry of <sup>177</sup>Lu-DOTA-ZOL for therapy of bone metastases.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 1, p. 1, doi. 10.2967/jnumed.120.255851
- By:
- Publication type:
- Article
Diagnostic accuracy of <sup>18</sup>F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.246363
- By:
- Publication type:
- Article
Diagnostic accuracy of <sup>18</sup>F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.246363
- By:
- Publication type:
- Article
Diagnostic accuracy of <sup>18</sup>F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.246363
- By:
- Publication type:
- Article
Diagnostic accuracy of <sup>18</sup>F-PSMA-1007-PET/CT imaging for lymph node staging of prostate carcinoma in primary and biochemical recurrence.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.246363
- By:
- Publication type:
- Article
Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2020, v. 5, n. 1, p. 1, doi. 10.1186/s41181-020-00102-z
- By:
- Publication type:
- Article
Pharmacokinetic evaluation of [18F]PR04.MZ for PET/CT imaging and quantification of dopamine transporters in the human brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 8, p. 1927, doi. 10.1007/s00259-019-04594-z
- By:
- Publication type:
- Article
Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 2, p. 355, doi. 10.1007/s00259-019-04527-w
- By:
- Publication type:
- Article
Prodromal manifestations of Parkinson disease in adults with 22q11.2 microdeletion syndrome.
- Published in:
- Contacto Científico Clínica Alemana, 2019, v. 9, n. 3, p. 61
- By:
- Publication type:
- Article
Detection Efficacy of <sup>18</sup>F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 362, doi. 10.2967/jnumed.118.212233
- By:
- Publication type:
- Article
Direct radiofluorination of [<sup>18</sup>F]MH.MZ for 5-HT<sub>2A</sub> receptor molecular imaging with PET.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 9, p. 354, doi. 10.1002/jlcr.2947
- By:
- Publication type:
- Article
Structural Combination of Established 5-HT<sub>2A</sub> Receptor Ligands: New Aspects of the Binding Mode.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Synthesis of novel WAY 100635 derivatives containing a norbornene group and radiofluorination of [<sup>18</sup>F]AH1.MZ as a serotonin 5-HT<sub>1A</sub> receptor antagonist for molecular imaging.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2009, v. 52, n. 6, p. 201, doi. 10.1002/jlcr.1589
- By:
- Publication type:
- Article